Effect of bacterial extracts on the immunologic profile in chronic relapsing Brucellosis patients

International Journal of Immunopathology and Pharmacology

Volumn 12, Issue 2, 1999, Pages 103-111

  Boura, P ^a   Skendros, P ^a   Kountouras, J ^a   Zacharioudaki, E ^a   Tsapas, G ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Bacterial extracts; Chronic brucellosis; Immunomodulation; Klebsiella pneumoniae; Monocyte macrophage system

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; CANDIDA ANTIGEN; CASEIN; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULIN;

ADULT; AGED; ARTICLE; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLOSIS; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KLEBSIELLA PNEUMONIAE; LEUKOCYTE MIGRATION; MACROPHAGE; MALE; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; SKIN TEST;

EID: 0032765592     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Nimier K., D. Robic and R. Bourbouze. 1994. Macromolecular aggregation of F1 and P1 fractions of RU 41740 an immunomodulating compound isolated from Klebsiella pneumoniae, as revealed by size exclusion high performance liquid chromatography and light scattering detection. Int. J. Pharmaceutics 105:235.
2. Garin L., J. Bernaud, N. Picot, et al. 1996. RU 41740 (BIOSTIM) and IL-4 or IL-13 have opposite effects on CD14, CD23, HLA-DR and HLA-DQ on monocytes. Int. J. Immunopharmacol. 18:69.
3. Capsoni F., F. Minonzio, A.M. Ongari, P. Bonara, G. Guidi and C. Zanussi. 1991. Increased expression of C3b and C3b1 receptors on human neutrophils and monocytes induced by a glycoprotein extract from Klebsiella pneumoniae (RU 41740). Int. J. Immunopharmacol. 13:227.
4. Blomgen H. and H. Viland. 1991. Responsiveness of human monocytes to Ru 41740 (Biostim). Influence of preincubation in vitro. Anticancer Res. 11:1849.
5. Meredith C. and K. Miller. 1994. Molecular immunotoxicology testing in vitro. Toxicol. in vitro 8:1001.
6. Meredith C. and M.P. Scott. 1994. Altered gene expression in immunotoxicology screening in vitro: Comparison with ex vivo analysis. Toxicol. in vitro 8:751.
7. Blomgen H. 1992. Ru41740 triggers mononuclear blood cells to release tumor growth inhibitory factors in vitro. Int. J. Immunopharmacol. 14:185.
8. Afeltra A., A. Amoroso, G.M. Feri, P. Basso, G. Guidi and L. Bonomo. 1991. In vivo effects of Ru 41740 in aged humans; evaluation of some immunological parameters. Allergol. Immunopathol.(Madr.). 19:161.
9. Frenoy M., C. Mandray, B. Leduc and B. Fournet. 1994. Bacterial clearance in mice assessed by a conductance method is enhanced by RU 41740 (Biostim). Lett. Appl. Microbiol. 18:93.
10. Finlay-Jones J.J., A.N. Boyden, E.J. Tillett, et al. 1993. The effects of RU 41740, a glycoprotein immunomodulating agent derives from Klebsiella pneumoniae, on intra-abdominal abscess formation in mice. J. Med. Microbiol. 38:454.
11. Dunis I. 1992. Determination of antiinfectious activity of RU 41740 (biostim) as an example of an immunomodulator. Adv. Exp. Med. Biol. 319:165.
12. DeWaziers B., V. Spehner, S. Harraga, et al. 1998. Alteration in the production of free oxygen radicals and proinflammatory cytokines by peritoneal and alveolar macrophages in old mice and immunomodulatory effect of RU 41740 administration. Part I: Effect of short and repetitive noise stress. Immunopharmacology 39:51.
13. Profeta M.C., G. Guidi, P.L. Meroni, et. al. 1987. Influenza vaccination with adjuvant RU 41740 in the elderly. Lancet 8539:973.
14. Fietta A.M., C. Merlini, M. Uccelli, G. Giardoni and C. Grassi. 1992. Immunological and clinical effect of long-term oral treatment with RU 41740 in patients with chronic bronchitis; double trial long-term versus standard dose regimen. Respiration 59:253.
15. Reinert P., M. Morales, S. Brin and T. Fagnani. 1995. Evaluation of RU 41740 (Biostim) for the prevention of recurrent nasopharyngcal infections in pediatric patients. Ann. Pediatr. (Paris). 42:454.
16. Leinor G. and D.D. Sommelet. 1991. A double blind comparison of RU41740 (Biostim) and placebo in recurrent upper respiratory tract infections in children with cystic fibrosis. Drug Investigation 3:176.
17. Cotuzzo E. and C. Carrilo. 1992. Brucella. In Infectious Diseases. S.L. Gorbach, J.G. Bartlett and N.R. Blacklow, ed. W.B. Saunders Comp. Philadelphia, p. 1513.
18. Boura P., M. Raptopoulou-Gigi and G. Goulis. 1983. Peripheral blood monocyte phagocytosis in patients with chronic brucellosis. J. Immunopharmacol. 4:377.
19. Boura P., M. Raptopoulou-Gigi and G. Goulis. 1984. Reevaluation of the effect of levamisole in chronic brucellosis: in vitro and in vivo effect on monocyte phagocytosis. J. Immunopharmacol. 6:135.
20. Boura P., G. Tsapas, J. Kountouras and E. Zaharioudaki. 1995. Interferon-A 2a administration in chronic anergic brucellosis. Hepatogastrenterology 42:919.
21. Boura P., G. Tsapas, A. Papadopoulou, I. Magoula and J. Kountouras. 1989. Monocyte locomotion in anergic chronic brucellosis: the in vivo effect of ascorbic acid. Immunopharmacol. Immunotoxicol. 11:119.
22. Rose N., P. Bigazzi, W. Bartholomew and R. Zarco. 1973. Complement determinations. In Methods in Immunodiagnosis. N.R. Rose, P.E. Bigazzi, ed. John Wiley and Sons Inc. New York, p. 33.
23. Rose N., P. Bigazzi, W. Bartholomew, R. Zarco, K. Wichcr, E. Gorzynski and C. Abeyounis. 1973. Agglutination reactions. In Methods in Immunodiagnosis. N.R. Rose, P.E. Bigazzi, ed. John Wiley and Sons Inc. New York, p. 45.
24. Bendixen G. and M. Soborg. 1969. A leukocyte migration technique for in vitro detection of cellular (delayed type) hypersensitivity in man. Dan. Med. Bull. 16:1.
25. MacCuish A.C., S.J. Urbaniak, A.H. Goldstone and W.J. Irvine. 1974. PHA responsiveness and subpopulations of circulating lymphocytes in pernicious anaemia. Blood. 44:849.
26. Wilkinson P.C. 1977. Neutrophil leukocyte function test. In Technics in Clinical Immunology. R. A. Thompson, ed. Blackwell Scientific Publications. Oxford, p. 201.
27. Zuckerman S., S. Ackerman and S.D. Douglas. 1979. Long-term human peripheral monocyte cultures: establisment, metabolism and morphology of primary human monocyte-macrophage cell cultures. Immunology 38:401.
28. Huber H., S. Douglas and H.H. Fudenberg. 1969. The IgG receptor: an immunological marker for the characterization of mononuclear cells. Immunology 17:7.
29. Elson C.J. and S.J. Thompson. 1994. Immunity, autoimmunity and immunotherapy: new frontiers in heat shock proteins research. Clin. Exp. Immunol. 98:175.
30. Kaklamani E., Y. Koumantaki, D. Karalis, et al. 1991. Klebsiella pneumoniae glycoprotein RU 41740 enhances resistance of mice against Mycoplasma arthritidis-induced arthritis. FEMS Microbiol. Immunol. 76:205.
31. Moreland L. W. and W.J. Koopman. 1991. Infection as a cause of arthritis. Curr. Opin. Rheumatol. 3:639.
32. Lahesmaa R., M. Skurnik, D. Karalis, et al. 1992. Molecular mimicry in the pathogenesis of spondylarthropathies. A criti appraisal of cross-reactivity between microbial antigens and HLA-B27. Br. J. Rheumatol. 31:221.
33. Mosmann T.R. and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138.
34. Hadden J.W. 1994. T-cells adjuvants. Int. J. Immunopharmacol. 16:703.
35. Rogers H., C. Tripp and E. Unanue. 1995. Different stages in the natural and acquired resistance to an intracellular pathogen. The Immunologist 3:152.
36. Reiner N.E. 1994. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol. Today 15:374.